(Q40621627)

22 September 2017

title

Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor (English)

1 reference

22 September 2017

main subject

Orthoebolavirus zairense

0 references

author name string

M Bray

series ordinal

1

1 reference

22 September 2017

J Driscoll

series ordinal

2

1 reference

22 September 2017

J W Huggins

series ordinal

3

1 reference

22 September 2017

publication date

1 February 2000

1 reference

22 September 2017

1 reference

22 September 2017

volume

45

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

135-147

1 reference

A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Pathogenesis of experimental Ebola virus infection in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Pharmacokinetics of the antiviral agent 3-deazaneplanocin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Carbocyclic Adenosine Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Antiviral Agents: Recent Advances

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Broad-spectrum antiviral activity of adenosine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Differentiation of filoviruses by electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Effects of an S-adenosyl-L-homocysteine hydrolase inhibitor on murine macrophage activation and function

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Rational approaches to the design of antiviral agents based on S-adenosyl-L-homocysteine hydrolase as a molecular target

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Biologic differences between strains of Ebola virus from Zaire and Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Plaque assay for Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Reemergence of Ebola virus in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

3-Deazaadenosine--an inhibitor of interleukin 1 production by human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Ebola virus virulence for newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900066-8

7 January 2021

10.1016/S0166-3542(00)00066-8

Identifiers

DOI

1 reference

22 September 2017

1 reference